Business Description
Krystal Biotech is a Pittsburgh-based biotechnology company founded in 2016 that develops and sells gene-based medicines for serious conditions that lack adequate treatment options. Its flagship product, VYJUVEK, is an approved therapy for dystrophic epidermolysis bullosa, a rare and painful skin disorder. The company also has a broad pipeline of treatments in various stages of clinical testing, targeting conditions ranging from cystic fibrosis and eye disease to certain cancers and skin conditions.
